2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

James Beer Biography and Net Worth

CFO of McKesson

James A. Beer is Independent Director of the company. Mr. Beer joined Atlassian Corporation PLC, a publicly traded company, as its CFO in February 2018. He was executive vice president and CFO for McKesson Corporation from 2013 to 2017, and CFO at Symantec Corp. from 2006 to 2013. From 1991 to 2006, he held a number of management positions including CFO at AMR Corporation and American Airlines, AMR’s principal subsidiary.

What is James A. Beer's net worth?: The estimated net worth of James A. Beer is at least $24.87 million as of November 19th, 2019. Mr. Beer owns 43,118 shares of McKesson stock worth more than $24,868,738 as of December 23rd. This net worth evaluation does not reflect any other assets that Mr. Beer may own. Learn More about James A. Beer's net worth.
How do I contact James A. Beer?: The corporate mailing address for Mr. Beer and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on James A. Beer's contact information.
Has James A. Beer been buying or selling shares of McKesson?: James A. Beer has not been actively trading shares of McKesson in the last ninety days. Most recently, James A. Beer sold 5,500 shares of the business's stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $199.00, for a transaction totalling $1,094,500.00. Following the completion of the sale, the chief financial officer now directly owns 12,412 shares of the company's stock, valued at $2,469,988. Learn More on James A. Beer's trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), Marie Knowles (Director), Erin Lampert (SVP), Maria Martinez (Director), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Susan Salka (Director), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 17 times. They sold a total of 55,337 shares worth more than $30,142,665.33. The most recent insider tranaction occured on December, 9th when EVP Leann B Smith sold 579 shares worth more than $349,026.99. Insiders at McKesson own 0.1% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 12/9/2024.

James A. Beer Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/14/2016	Sell	5,500	$199.00	$1,094,500.00	12,412

James A. Beer Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $576.76

$569.63

$579.96

50 Day Range

MA: $571.41

$499.18

$628.60

2 Week Range

Now: $576.76

$451.54

$637.51

Volume

517,106 shs

Average Volume

825,532 shs

Market Capitalization

$73.21 billion

P/E Ratio

29.87

Dividend Yield

0.50%

Beta

0.49